1. Mechanisms responsible for increased erythrocyte K+ efflux in vitro have been investigated in a patient with familial pseudohyperkalaemia. Mean net K+ efflux (4°C) was 108 nmol h−1 10−9 erythrocytes, seven times greater than the mean for controls (15.2 nmol h−1 10−9 erythrocytes). Net K+ efflux was not increased at 22°C or 37°C and losses at 4°C were reversed by subsequent incubation at 37°C.

2. Erythrocyte glucose consumption (4°C) was 14 nmol h−1 10−9 erythrocytes, similar to the mean for controls of 16.8 nmol h−1 10−9 erythrocytes. This suggests that the increased net K+ efflux (4°C) was not associated with abnormal energy consumption and was therefore unlikely to be due to an abnormality of the Na+, K+-pump.

3. Incubation of erythrocyte suspensions with ouabain (0.1 mmol/l) or frusemide (1 mmol/l) at 4°C or 37°C resulted in no differences in K+ efflux between patient and controls. Incubation with quinine (2 mmol/l), an inhibitor of the erythrocyte Ca2+-dependent K+ channel, reduced net K+ efflux at 4°C, but the effect persisted in Ca2+-depleted erythrocytes, implying that quinine was acting in a non-specific fashion.

4. Chemical pathologists and clinicians must be aware of this condition if inappropriate treatment of pseudohyperkalaemia is to be avoided.

This content is only available as a PDF.
You do not currently have access to this content.